Trademark: 90366509
Status Date
Monday, March 27, 2023
Filing Date
Tuesday, December 8, 2020
Published for Opposition
Tuesday, June 29, 2021
Abandoned Date
Monday, March 27, 2023
5 Pharmaceutical preparations for use in the treatment of tumorous diseases, B-cell disorders, autoimmune diseases, inflammation, metabolic diseases and disorders, hematological and hemolytic diseases and disorders, amyloidosis, infectious diseases, and minimal residual disease
Mar 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 27, 2023
Abandonment - No Use Statement Filed
Aug 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 3, 2022
Sou Extension 2 Granted
Aug 3, 2022
Sou Extension 2 Filed
Aug 3, 2022
Teas Extension Received
Apr 29, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 29, 2022
Teas Change Of Correspondence Received
Apr 29, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 29, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 29, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 29, 2022
Teas Change Of Owner Address Received
Jan 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2022
Sou Extension 1 Granted
Jan 24, 2022
Sou Extension 1 Filed
Jan 24, 2022
Teas Extension Received
Aug 24, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 29, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 29, 2021
Published For Opposition
Jun 9, 2021
Notification Of Notice Of Publication E-Mailed
May 27, 2021
Approved For Pub - Principal Register
May 27, 2021
Assigned To Examiner
Feb 12, 2021
New Application Office Supplied Data Entered
Dec 11, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
